MedPage Today on MSN
Paradigm Shift for Evaluating, Treating Biochemical Recurrence in Prostate Cancer
When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...
New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...
News-Medical.Net on MSN
PSMA PET/CT scans may predict prostate cancer recurrence, guide treatment
New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans ...
Near the end of 2025, the the St. Anthony Foundation received a $1 million donation from Carroll residents Mike and Amy McLaughlin. The donation will go towards the hospital’s new ...
Deep learning analysis of FDG PET-CT improves survival prediction in non-metastatic breast cancer, outperforming standard staging and single modality models while supporting interpretable and ...
Pentixafor PET/CT was well tolerated and demonstrated high specificity and moderate sensitivity for identifying unilateral ...
Total body PET/CT scans can successfully visualize systemic joint involvement in patients with autoimmune arthritis, according to new first-in-human research published in the October issue of The ...
WFXR Roanoke on MSN
Centra Foundation awarded $450K for cardiac PET/CT scanner
LYNCHBURG, Va. (WFXR)- The Centra Foundation was awarded a $450,000 grant from Al Stroobants Foundation to help fund a new ...
Prostate-specific membrane antigen (PSMA)-PET/CT imaging identified metastatic prostate cancer in almost half of high-risk cases missed by conventional imaging, a retrospective analysis showed.
BREWER, Maine (WABI) - For more than 15 years, Northern Light Cancer Care in Brewer has been helping patients facing a cancer diagnosis. Their goal is to make sure patients have all the care they need ...
Expert Rev Anticancer Ther. 2009;9(1):75-96. Based on the available data, FDG-PET alone appears to be of limited use in differentiating tumors of low malignant potential from benign tumors and ovarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results